Articles

EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information. 

 P360 Builds Out New Artificial Intelligence-Powered Platform

Patients with chronic inflammatory demyelinating polyneuropathy administered HyQvia showed a statistically significant difference between relapse rates compared with placebo.

HyQvia Gets FDA Approval for Chronic Inflammatory Demyelinating Polyneuropathy Maintenance 

JAMA Health Forum details the DSCSA and stresses the value of protecting the pharmaceutical supply chain from adulterated products. 

The Importance of Drug Supply Chain Security

Researchers from the University of Cambridge collaborated with Pfizer to develop a platform combining automated experiments with artificial intelligence to predict chemical reactions.

New Machine Learning Model May Accelerate Drug Development

Analysis examines how social and healthcare factors play a role. 

Study Provides Look Into Surgeons' Opioid Prescribing Patterns

Initiative seeks to find new therapies to improve the lives of patients with Rett syndrome.

Department of Defense Grant to Power Multisite Trial of Rett Syndrome Therapy

The list price of Casgevy for transfusion-dependent beta thalassemia has yet to be released, however, the cost for the treatment in sickle cell disease is $2.2 million.

FDA Approves CRISPR/Cas9 Gene-Edited Cell Therapy Casgevy for Transfusion-Dependent Beta Thalassemia

Zoryve (roflumilast) shows efficacy in seborrheic dermatitis and atopic dermatitis in clinical trials.

Zoryve Produces Promising Results in Dermatologic Conditions Across Recent Trials

Cureus report discuss the value of AI, but the medical community must remain aware of privacy pitfalls. 

The Benefits and Privacy Concerns in Utilizing Artificial Intelligence for Early Detection of Breast Cancer

Trial shows 52% of patients with atopic dermatitis with uncontrolled moderate-to-severe hand and/or foot involvement administered Dupixent experienced a clinically meaningful reduction in itch on hands and feet vs. 14% with placebo.

News